NucliThera

Nuclithera email format

Verified email-pattern data for Nuclithera is currently limited. You can still use the company insights and contact sections below.
NucliThera is an R&D company developing targeted short-range radionuclides for treating hematological cancers like lymphoma and leukemia. High-energy alpha- and beta-radiating nuclides are linked to targeting monoclonal antibodies or small molecules. They bind to cancer cells killing them with minimal damage to surrounding healthy tissue. The NucliThera research team is led by Dr. Roy H Larsen and Professor Emeritus Øyvind S Bruland. They have developed the only alpha-emitting cancer pharmaceutical approved by FDA so far – Xofigo against bone metastases from prostate cancer. Xofigo was acquired by Bayer Healthcare for US$ 2.9 billion in 2014.
Looking for a particular NucliThera employee's phone or email?

Nuclithera Questions

Explore related pages

Related company profiles:

Top NucliThera Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant